CAM
MRNA icon

ClariVest Asset Management’s Moderna MRNA Stock Holding History

ClariVest Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$364 Hold
3
– – ﹤0.01% 819
2024
Q2 		$364 Hold
3
– – ﹤0.01% 819
2024
Q1 		$332 Buy
+3
New +$302 ﹤0.01% 837
2023
Q4 		– Sell
-4
Closed – – 930
2023
Q3 		$0 Buy
+4
New +$446 ﹤0.01% 819
2021
Q2 		– Sell
-10
Closed -$1K – 798
2021
Q1 		$1K Hold
10
– – ﹤0.01% 676
2020
Q4 		$1K Hold
10
– – ﹤0.01% 698
2020
Q3 		$1K Hold
10
– – ﹤0.01% 688
2020
Q2 		$1K Buy
+10
New +$548 ﹤0.01% 745

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return